Patients treated with semaglutide (Ozempic / Wegovy) showed a 50% or greater reduction in the likelihood of both new alcohol use disorder (AUD) compared to patients treated with non GLP-1 anti-obesity or diabetes medications
Potential future treatments for CKD in type 1 diabetes Beyond the classes of medication discussed above, additional pharmacological treatments are being investigated for use in DKD that may be suitable for use in type 1 diabetes
Temperature control : Maintaining indoor temperatures at 68-72F (20-22C)
The Impact: Diabetes treatment costs could drop 60-70% 72M+ Indians with diabetes gain affordable access Indian pharma captures $2B+ market opportunity GLP-1 agonists transition from premium to accessible care This isn't just about genericsit's about democratizing diabetes management
Accelerated Metabolism: By supporting your metabolism, these injections can help you burn calories more efficiently, even during periods of rest.
IGF-1 LR3 has greater free tissue exposure for equivalent molar doses due to reduced binding-protein affinity, which amplifies that theoretical risk